Ariel Rubashkin
CEO - Allium Medical
Claimed by owner ProCatid Medical
Former names: Gardia Medical
Embolic Protection Solutions
ProCatid Medical
About
ProCatid Medical is the developer of WIRION, a distal embolic protection system composed of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires, according to physician preference. The unit can be placed anywhere on the wire using minimally invasive interventional procedures.
The WIRION system allows the physician to use any 0.014-inch guide wire of choice throughout the entire procedure, cross challenging anatomies, and lock the filter on the same guide wire anywhere along the wire.
The one-size system covers vessels ranging between 3.5 mm and 6.0 mm in diameter. Its uniform 120-micron pore filter provides continuous blood flow while maintaining embolic capture efficiency. It is currently designed for use in stenting procedures, including carotid, renal, lower limb, coronary, and SVG angioplasty. The system is CE marked and FDA cleared.
ProCatid Medical is a subsidiary of Allium Medical, which develops minimally invasive solutions for treating chronic progressive diseases.
In August 2019, the ProCatid Medical entered into an asset purchase agreement with Cardiovascular Systems Inc for the acquisition of certain assets and rights in relation to the WIRION system.
The WIRION system allows the physician to use any 0.014-inch guide wire of choice throughout the entire procedure, cross challenging anatomies, and lock the filter on the same guide wire anywhere along the wire.
The one-size system covers vessels ranging between 3.5 mm and 6.0 mm in diameter. Its uniform 120-micron pore filter provides continuous blood flow while maintaining embolic capture efficiency. It is currently designed for use in stenting procedures, including carotid, renal, lower limb, coronary, and SVG angioplasty. The system is CE marked and FDA cleared.
ProCatid Medical is a subsidiary of Allium Medical, which develops minimally invasive solutions for treating chronic progressive diseases.
In August 2019, the ProCatid Medical entered into an asset purchase agreement with Cardiovascular Systems Inc for the acquisition of certain assets and rights in relation to the WIRION system.
Primary Sector
Life Sciences & HealthTech
Products
WIRION
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
0
Investors
0
The Team
(3)
UR
Uri Rosenschein
Founder
EH
Eitan Hod
VP QA/RA
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Media gallery
(3)
Gardia Medical - The WIRION is a distal embolic protection system
Live Case from LINC 2010
Allium Medical - WIRION Embolic Protection Device - PCR 2013 - Live Case
Locations
Israel
Ha-Eshel Street 2, Caesarea, Israel
Locations
Israel
Ha-Eshel Street 2, Caesarea, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,